1 November 2023
HEADLINES â— Full price sales1 in the third quarter (August – October) were up +4.0% on last year, £23m ahead of our guidance which was to…
AstraZeneca PLC 01 November 2023 01 November 2023 AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions…
GSK PLC 01 November 2023 Strong year-to-date and Q3 performance drives upgrade to full-year guidance Broad-based execution drives further sales and earnings growth: •…
31 October 2023
31 October 2023 Custodian Property Income REIT plc (“Custodian Property Income REIT” or “the Company”) Second quarter trading update shows rental growth supporting fully…
Sale of Vodafone Spain 31 October 2023 Vodafone Group Plc (“Vodafone”) announces that it has entered into binding agreements with Zegona Communications plc (“Zegona”)1 in…
Performing while transforming Financial summary Third Second Third Nine Nine quarter quarter quarter months months $ million 2023…
BP p.l.c. ———————- Share Repurchases ———————- 31 October 2023 BP p.l.c. (the “Company“) announces that it is to commence a share buyback programme to…
30 October 2023
Phase III RUBY trial of Jemperli (dostarlimab) plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer · Statistically significant and…